Background illustration for clinical trials search

Paid Clinical Trials Annapolis

Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,396

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for

CRC (Colorectal Cancer)

Location: Baltimore MD, Brandywine MD, Bethesda MD, York PA,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for

Triple Negative Breast Cancer

Location: Baltimore MD, Washington D.C. DC, Towson MD, Fairfax VA,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients

for

Morbid Obesity

Location: Baltimore MD

Sponsor: Singh, Kuldeep, M.D., P.A.

Sex: All

Age: 18 - 65

Code: NCT02315105

Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for

Patients With Non-Small Cell Lung Cancer

Location: Baltimore MD, Washington D.C. DC, New York NY,

Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase3, Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for

Smoldering Plasma Cell Myeloma

Location: Baltimore MD, Hershey PA, West Reading PA, Camden NJ,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase3, Recruiting

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

for

Type 1 Diabetes, Type 2 Diabetes,

Location: Baltimore MD

Sponsor: Johns Hopkins University

Sex: All

Age: 8 - 21

Code: NCT05463289

Recruiting

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

for

Glioblastoma (GBM)

Location: Baltimore MD

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT07375992

Recruiting

Barriers to Vegetarian Diets

for

Chronic Disease

Location: Baltimore MD

Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT07075653

Recruiting

Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record

for

Sudden Infant Death, Sudden Unexplained Infant Death

Location: Baltimore MD

Sponsor: Johns Hopkins University

Sex: All

Age: 0 - 70+

Code: NCT05503771

Recruiting

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

for

HIV Infections

Location: Baltimore MD

Sponsor: American Gene Technologies International Inc.

Sex: All

Age: 18 - 60

Code: NCT03215004

Recruiting

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B

for

Chronic Hepatitis B

Location: Baltimore MD

Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT06154278

Phase2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for

Non-small Cell Lung Cancer,

Location: Baltimore MD, Fairfax VA, New York NY, Norwalk CT,

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for

Metastatic Prostate Cancer

Location: Baltimore MD, Silver Spring MD, Fairfax VA,

Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase1, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for

Acute Myeloid Leukemia,

Location: Baltimore MD, Chapel Hill NC, Winston-Salem NC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase1, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for

Prostate Cancer,

Location: Baltimore MD, Hershey PA, Philadelphia PA, New York NY,

Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase1, Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

for

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Location: Baltimore MD, Bel Air MD, Charlottesville VA,

Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT05646316

Phase3, Recruiting

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

for

Advanced Solid Tumors

Location: Baltimore MD, Whittier CA, Los Angeles CA

Sponsor: Zhejiang Haichang Biotech Co., Ltd.

Sex: All

Age: 18+

Code: NCT05267899

Phase1, Recruiting

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

for

Small-cell Lung Cancer, Small Cell Lung Carcinoma

Location: Baltimore MD

Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT05450965

Phase2, Recruiting

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

for

Metastatic Castration-resistant Prostate Cancer

Location: Baltimore MD, Philadelphia PA, New Brunswick NJ,

Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05125016

Phase1, Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for

Mantle Cell Lymphoma, B Cell Lymphoma

Location: Baltimore MD, Gainesville VA, Hershey PA,

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

Paid Clinical Trials Annapolis

Filter results

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Interested in new trials?

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Barriers to Vegetarian Diets

Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)